http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1156830-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97a832097f121776ffcec244bc7bb41f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41fd78166a212287993b341fc50af449
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
filingDate 2000-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc39e9f9a1266af9d112fc05d29abb97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5174ff9178a94dbe9c01096361d41ebf
publicationDate 2001-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1156830-A2
titleOfInvention Oil-in-water emulsion for the use as medicament or for producing a medicament
abstract The present invention relates to an oil-in-water emulsion having the following composition: 0.01-30 % polydimethylsiloxane that has a degree of polymerisation of n = 20-400 and kinematic viscosity of 20-1,300 mm<2>/s, 0.01-15 % hydrophile emulgator, 45-99 % biocompatible saline solution and 0.01-10 % dimethylsulfoxide. The inventive oil-in-water emulsion can be used for producing a medicament against systemic inflammation, intensive care, virus diseases such as hepatitis C and aids, ulcerative colitis, Chron's disease, Parkinson's disease, Alzheimer's disease, multiple sclerosis, infectious hospitalism and/or infections of viral and/or bacterial genesis, bronchial asthma, infections of the kidneys and the urinary tract, migraine, rheumatoid arthritis, Sudeck's syndrome, acute and chronic inflammations, phlebitis, arteritis, acute and chronic states of exhaustion, tumours, muscular dystrophy and/or atrophy, haemorrhoids, chronic ischaemic heart disease, hypertonia, aging processes, acute and chronic pain, spasticities, polyneuropathies, prostate neoplasia, psilosis, impotence, neurodermitis, cervical syndrome, tissue traumatism or for the treatment thereof.
priorityDate 1999-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20055127
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID52152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID52152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109

Total number of triples: 32.